The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Chromatin & Transcription | Molecular Biology of Disease
The EMBO Journal (2005) 24, 2391–2402, doi:10.1038/sj.emboj.7600719
Published online 16 June 2005
Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation
Lizi Wu1, 2, Jingxuan Liu1, 2, Ping Gao1, 2, Makoto Nakamura1, 2, Yang Cao1, 2, Huangxuan Shen1, 2 and James D Griffin1, 2
1 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
2 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

To whom correspondence should be addressed
Lizi Wu, Department of Medical Oncology, Dana-Farber Cancer Institute, Mayer 540, 44 Binney Street, Boston, MA 02115, USA. Tel.: +1 617 632 5451; Fax: +1 617 632 4388; E-mail: lizi_wu@dfci.harvard.edu

Received 12 November 2004; Accepted 26 May 2005; Published online 16 June 2005.
Abstract
Salivary gland tumors, a group of histologically diverse benign and malignant neoplasms, represent a challenging problem for diagnosis and treatment. A specific recurring t(11;19)(q21;p13) translocation is associated with two types of salivary gland tumors, mucoepidermoid carcinomas and Warthin's tumors. This translocation generates a fusion protein comprised of the N-terminal CREB (cAMP response element-binding protein)-binding domain of the CREB regulator MECT1 (Mucoepidermoid carcinoma translocated-1) and the C-terminal transcriptional activation domain of the Notch coactivator Mastermind-like 2 (MAML2). Here, we demonstrate that the MECT1-MAML2 fusion protein induces expression of multiple genes known to be CREB transcriptional targets. MECT1-MAML2 was found to bind to CREB, recruit p300/CBP into the CREB complex through a binding domain on MAML2, and constitutively activate CREB-dependent transcription. The transforming activity of MECT1-MAML2 was markedly reduced by blocking CREB DNA binding. Thus, this fusion oncogene mimics constitutive activation of cAMP signaling, by activating CREB directly. This study has identified a novel, critical mechanism of transformation for an oncogene associated very specifically with salivary gland tumors, and identified potential targets for the development of novel therapies.
Keywords: CREB, MECT1-MAML2 fusion, mucoepidermoid carcinoma, transformation, Warthin's tumor
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Human therapeutic proteins from silkworms

Nature Biotechnology Research News (01 Jan 2003)

A growing coactivator network

Nature News and Views (05 Sep 1996)

See all 6 matches for News And Views

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2005 by the European Molecular Biology Organization